The role of transforming growth factor β in glaucoma and the therapeutic implications

British Journal of Ophthalmology

Volumn 97, Issue 6, 2013, Pages 680-686

  Prendes, Mark A ^a   Harris, Alon ^a   Wirostko, Barbara M ^b   Gerber, Austin L ^a   Siesky, Brent ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR OUTFLOW; CATARACT; CELL POPULATION; CLOSED ANGLE GLAUCOMA; DISEASE COURSE; EXTRACELLULAR MATRIX; GENETIC ASSOCIATION; GLAUCOMA; HUMAN; INFLAMMATION; INTRAOCULAR HYPERTENSION; NONHUMAN; OPTIC NERVE; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TGF BETA1 GENE; TGF BETA2 GENE; TRABECULAR MESHWORK;

ANTERIOR CHAMBER; AQUEOUS HUMOUR; GLAUCOMA; INTRAOCULAR PRESSURE; PATHOLOGY;

GLAUCOMA; HUMANS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84877263696     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-301132     Document Type: Review

References (88)

1. de Caestecker M. The Transforming Growth Factor-β superfamily of receptors. Cytokine Growth Factor Rev 2004;15:1-11.
2. Saika S. TGF beta pathobiology in the eye. Lab Invest 2006;86:106-15.
3. Wang W, Koka V, Lan HY. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005;10:48-56. (Pubitemid 40349406)
4. Shi Y, Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700. (Pubitemid 36724933)
5. Tandon A, Tovey JC, Sharma A, et al. Role of transforming growth factor beta in corneal function, biology and pathology. Curr Mol Med 2010;10:565-78.
6. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003;48:314-46. (Pubitemid 36549254)
7. Das P, Golde T. Dysfunction of TGF-beta signaling in Alzheimer's disease. J Clin Invest 2006;116:2855-7. (Pubitemid 44684467)
8. Mehta JL, Attramadal H. The TGFbeta superfamily in cardiovascular biology. Cardiovasc Res 2007;74:181-3.
9. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol 1990;144:3021-7. (Pubitemid 20149474)
10. Tripathi RC, Li J, Chan WF, et al. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 1994;59:723-7.
11. Allen JB, Davidson MG, Nasisse MP, et al. The lens influences aqueous humor levels of transforming growth factor-beta 2. Graefes Arch Clin Exp Ophthalmol 1998;236:305-11. (Pubitemid 28152217)
12. Pasquale LR, Dorman-Pease ME, Lutty GA, et al. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 1993;34:23-30. (Pubitemid 23045098)
13. Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol 2002;46:249-53. (Pubitemid 34626632)
14. Ozcan AA, Ozdemir N, Canataroglu A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int Ophthalmol 2004;25:19-22. (Pubitemid 38443407)
15. Min SH, Lee TI, Chung YS, et al. Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes. Korean J Ophthalmol 2006;20:162-5.
16. Stefan C, Dragomir L, Dumitricǎ DM, et al. TGF-beta2 involvements in open angle glaucoma (Romanian). Oftalmologia 2008;52:110-12.
17. Inatani M, Tanihara H, Katsuta H, et al. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol 2001;239:109-13. (Pubitemid 32288460)
18. Yoneda K, Nakano M, Mori K, et al. Disease-related quantitation of TGF-beta3 in human aqueous humor. Growth Factors 2007;25:160-7. (Pubitemid 350214965)
19. Yu XB, Sun XH, Dahan E, et al . Increased levels of transforming growth factor-betal and-beta2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2007;38:6-14. (Pubitemid 46207322)
20. Yamamoto N, Itonaga K, Marunouchi T, et al. Concentration of transforming growth factor beta2 in aqueous humor. Ophthalmic Res 2005;37:29-33. (Pubitemid 40663231)
21. Picht G, Welge-Luessen U, Grehn F, et al. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 2001;239:199-207. (Pubitemid 32422026)
22. Trivedi RH, Nutaitis M, Vroman D, et al. Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes. J Ocul Pharmacol Ther 2011;27:477-80.
23. Wordinger RJ, Clark AF, Agarwal R, et al. Cultured human trabecular meshwork cells express functional growth factor receptors. Invest Ophthalmol Vis Sci 1998;39:1575-89. (Pubitemid 28361318)
24. Borisuth NS, Tripathi BJ, Tripathi RC. Identification and partial characterization of TGF-beta 1 receptors on trabecular cells. Invest Ophthalmol Vis Sci 1992;33:596-603.
25. Tripathi RC, Li J, Borisuth NS, et al. Trabecular cells of the eye express messenger RNA for transforming growth factor-beta 1 and secrete this cytokine. Invest Ophthalmol Vis Sci 1993;34:2562-9. (Pubitemid 23206486)
26. Bhattacharya SK, Gabelt BT, Ruiz J, et al. Cochlin expression in anterior segment organ culture models after TGFbeta2 treatment. Invest Ophthalmol Vis Sci 2009;50:551-9.
27. Birke MT, Birke K, Lütjen-Drecoll E, et al. Cytokine-dependent ELAM-1 induction and concomitant intraocular pressure regulation in porcine anterior eye perfusion culture. Invest Ophthalmol Vis Sci 2011;52:468-75.
28. Shepard AR, Millar JC, Pang IH, et al. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces out flow facility in rodent eyes. Invest Ophthalmol Vis Sci 2010;51:2067-76.
29. Robertson JV, Golesic E, Gauldie J, et al . Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats. Invest Ophthalmol Vis Sci 2010;51:308-18.
30. Cao Y, Wei H, Pfaffl M, et al. Apoptosis of human trabecular meshwork cells induced by transforming growth factor-beta2 in vitro. J Huazhong Univ Sci Technolog Med Sci 2004;24:87-9, 94.
31. Cao Y, Wei H, Da B, et al. Effect of transforming growth factor-beta 2 on phagocytosis in cultured bovine trabecular meshwork cells. J Tongji Med Univ 2001;21:318-20. (Pubitemid 41289830)
32. Da B, Cao Y, Wei H, et al. Antagonistic effects of tranilast on proliferation and collagen synthesis induced by TGF-beta2 in cultured human trabecular meshwork cells. J Huazhong Univ Sci Technolog Med Sci 2004;24:490-2, 496.
33. Tamm ER, Siegner A, Baur A, et al. Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res 1996;62:389-97. (Pubitemid 26150372)
34. Read AT, Chan DW, Ethier CR. Actin structure in the outflow tract of normal and glaucomatous eyes. Exp Eye Res 2007;84:214-26. (Pubitemid 44792069)
35. Clark AF, Wilson K, McCartney MD, et al. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-94. (Pubitemid 24046852)
36. Tan JC, Peters DM, Kaufman PL. Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol 2006;17:168-74. (Pubitemid 43790813)
37. Vittitow J, Borrás T. Genes expressed in the human trabecular meshwork during pressure-induced homeostatic response. J Cell Physiol 2004;201:126-37. (Pubitemid 39187051)
38. Gottanka J, Chan D, Eichhorn M, et al. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci 2004;45:153-8. (Pubitemid 38055681)
39. Chudgar SM, Deng P, Maddala R, et al. Regulation of connective tissue growth factor expression in the aqueous humor outflow pathway. Mol Vis 2006;12:1117-26. (Pubitemid 44480568)
40. Zhong L, Li M. Transforming growth factor-beta1 induced cultured human trabecular cells to produce elastin (Chinese). Zhonghua Yan Ke Za Zhi 1999;35:383-5.
41. Fuchshofer R, Yu AH, Welge-Lüssen U, et al . Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2007;48:715-26. (Pubitemid 351260705)
42. Cao Y, Wei H, Zhang Y, et al. Effect of transforming growth factor-beta(2) on extracellular matrix synthesis in bovine trabecular meshwork cells. Zhonghua Yan Ke Za Zhi 2002;38:429-32.
43. Li J, Tripathi BJ, Tripathi RC. Modulation of pre-mRNA splicing and protein production of fibronectin by TGF-beta2 in porcine trabecular cells. Invest Ophthalmol Vis Sci 2000;41:3437-43.
44. Li M, Li M. The effect of transforming growth factor-beta 1 on the secretion of collagen type IV in cultured human trabecular cells (Chinese). Yan Ke Xue Bao 2000;16:217-19.
45. Fleenor DL, Shepard AR, Hellberg PE, et al. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci 2006;47:226-34. (Pubitemid 46780818)
46. Welge-Lüssen U, May CA, Eichhorn M, et al. AlphaB-crystallin in the trabecular meshwork is inducible by transforming growth factor-beta. Invest Ophthalmol Vis Sci 1999;40:2235-41. (Pubitemid 29418377)
47. Zhao X, Ramsey KE, Stephan DA, et al. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest Ophthalmol Vis Sci 2004;45:4023-34. (Pubitemid 39411157)
48. Fuchshofer R, Welge-Lussen U, Lütjen-Drecoll E. The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp Eye Res 2003;77:757-65. (Pubitemid 37373590)
49. Alexander JP, Samples JR, Van Buskirk EM, et al. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991;32:172-80.
50. Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res 1998;17:276-85. (Pubitemid 28138275)
51. Schlotzer-Schrehardt U, Zenkel M, Kuchle M, et al. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoefoliation syndrome. Exp Eye Res 2001;73:765-80. (Pubitemid 34112103)
52. Konstas A, Koliakos G, Karabatsas C, et al . Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp Eye Res 2006;82:319-22. (Pubitemid 43122118)
53. Fatma N, Kubo E, Toris CB, et al. PRDX6 attenuates oxidative stress-and TGFbeta-induced abnormalities of human trabecular meshwork cells. Free Radic Res 2009;43:783-95.
54. Yu AL, Birke K, Moriniere J, et al. TGF-beta2 induces senescence-associated changes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2010;51:5718-23.
55. Nakamura Y, Hirano S, Suzuki K, et al. Signaling mechanism of TGF-beta1-induced collagen contraction mediated by bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci 2002;43:3465-72. (Pubitemid 35334354)
56. Beeser A, Ghernoff J. Rho GTPases and cell motility. In: Symons M ed. Rho GTPases. New York: Kluwer Academic/Plenum Publishers, 2004:141-54.
57. Nakamura Y, Sagara T, Seki K, et al. Permissive effect of fibronectin on collagen gel contraction mediated by bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci 2003;44:4331-6. (Pubitemid 37186267)
58. Liton PB, Liu X, Challa P, et al. Induction of TGF-beta1 in the trabecular meshwork under cyclic mechanical stress. J Cell Physiol 2005;205:364-71. (Pubitemid 41598850)
59. Li J, Tripathi BJ, Chalam KV, et al. Transforming growth factor-beta 1 and -beta 2 positively regulate TGF-beta 1 mRNA expression in trabecular cells. Invest Ophthalmol Vis Sci 1996;37:2778-82. (Pubitemid 27026566)
60. Flügel-Koch C, Ohlmann A, Fuchshofer R, et al. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. Exp Eye Res 2004;79:649-63. (Pubitemid 39410368)
61. Gonzalez P, Epstein DL, Borrás T. Genes upregulated in the human trabecular meshwork in response to elevated intraocular pressure. Invest Ophthalmol Vis Sci 2000;41:352-61. (Pubitemid 30080434)
62. Klemenz R, Fröhli E, Steiger RH, et al. Alpha B-crystallin is a small heat shock protein. Proc Natl Acad Sci USA 1991;88:3652-6. (Pubitemid 21916681)
63. Siegner A, May CA, Welge-Lüssen UW, et al. alpha B-crystallin in the primate ciliary muscle and trabecular meshwork. Eur J Cell Biol 1996;71:165-9. (Pubitemid 26348472)
64. Lütjen-Drecoll E, May CA, Polansky JR, et al. Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork. Invest Ophthalmol Vis Sci 1998;39:517-25. (Pubitemid 28110683)
65. Iwaki T, Kume-Iwaki A, Goldman JE. Cellular distribution of alpha B-crystallin in non-lenticular tissues. J Histochem Cytochem 1990;38:31-9. (Pubitemid 20020865)
66. Bennardini F, Wrzosek A, Chiesi M. Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments. Circ Res 1992;71:288-94.
67. Tamm ER, Russell P, Epstein DL, et al. Modulation of myocilin/TIGR expression in human trabecular meshwork. Invest Ophthalmol Vis Sci 1999;40:2577-82. (Pubitemid 29455486)
68. Fautsch MP, Bahler CK, Jewison DJ, et al. Recombinant TIGR/MYOC increases out flow resistance in the human anterior segment. Invest Ophthalmol Vis Sci 2000;41:4163-8.
69. Konz DD, Flügel-Koch C, Ohlmann A, et al. Myocilin in the trabecular meshwork of eyes with primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2009;247:1643-9.
70. Welge-Lüssen U, May CA, Lütjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2. Invest Ophthalmol Vis Sci 2000;41:2229-38. (Pubitemid 30450997)
71. Sethi A, Mao W, Wordinger RJ, et al. Transforming growth factor-beta induces extracellular matrix protein cross-linking Lysyl Oxidase (LOX) genes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2011;52:5240-50.
72. Wordinger RJ, Fleenor DL, Hellberg PE, et al. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci 2007;48:1191-200. (Pubitemid 351261414)
73. Tamm ER, Fuchshofer R. What increases outflow resistance in primary open-angle glaucoma? Surv Ophthalmol 2007;52(Suppl 2):S101-4. (Pubitemid 350060958)
74. Liton PB, Li G, Luna C, et al. Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. Mol Vis 2009;15:326-34.
75. Pena JD, Taylor AW, Ricard CS, et al. Transforming growth factor beta isoforms in human optic nerve heads. Br J Ophthalmol 1999;83:209-18. (Pubitemid 29106092)
76. Fukuchi T, Ueda J, Hanyu T, et al. Distribution and expression of transforming growth factor-beta and platelet-derived growth factor in the normal and glaucomatous monkey optic nerve heads. Jpn J Ophthalmol 2001;45:592-9. (Pubitemid 34081772)
77. Kirwan RP, Crean JK, Fenerty CH, et al. Effect of cyclical mechanical stretch and exogenous transforming growth factor-(beta)1 on matrix metalloproteinase-2 activity in lamina cribrosa cells from the human optic nerve head. J Glaucoma 2004;13:327-34. (Pubitemid 38944202)
78. Sripriya S, George R, Arvind H, et al. Transforming growth factor beta-1-509C>T polymorphism in Indian patients with primary open angle glaucoma. Mol Diagn Ther 2007;11:151-4. (Pubitemid 46983406)
79. Challa P. Glaucoma genetics. Int Ophthalmol Clin 2008;48:73-94.
80. Challa P. Genetics of adult glaucoma. Int Ophthalmol Clin 2011;51:37-51.
81. Agarwal R, Agarwal P. Future target molecules in antiglaucoma therapy: TGF-beta may have a role to play. Ophthalmic Res 2010;43:1-10.
82. Hennessy AL, Robin AL. Anecortave acetate: a new approach for the medical treatment of glaucoma. In: Schacknow PN, Samples JR, eds. The glaucoma book. New York, NY: Springer Science+Business Media, 2010:989-93.
83. Spiecker M, Lorenz I, Marx N, et al. Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells. Mol Pharmacol 2002;62:856-63.
84. Suzawa H, Kikuchi S, Arai N, et al. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 1992;60:91-6.
85. Ikeda H, Inao M, Fujiwara K. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells. Biochem Biophys Res Commun 1996;227:322-7. (Pubitemid 26362805)
86. Yamada H, Tajima S, Nishikawa T, et al. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem 1994;116:892-7. (Pubitemid 24323674)
87. Suzawa H, Kikuchi S, Ichikawa K, et al. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from humanmonocytes-macrophages. Jpn J Pharmacol 1992;60:85-90.
88. Cao Y, Da BH, Wei HR. The inhibitory effect of tranilast on transforming growth factor-beta(2) expression in cultured human trabecular meshwork cells (Chinese). Zhonghua Yan Ke Za Zhi 2004;40:254-7.